FDA approves new Parkinson’s drug pioneered by UVA scientists
The federal Food and Drug Administration has approved a new Parkinson's disease drug that was based on research by UVA Health scientists.
Read original article on The Medical News →Related news
-
Scientists find strange bacterial immune system that works backward
United Kingdom
-
Early axial spondyloarthritis diagnosis linked to lower long-term spinal damage
United Kingdom
-
Prime editing repairs immune disorder defect in patient's own blood stem cells
United Kingdom
-
Hybrid AI architecture improves seizure prediction using EEG signals
United Kingdom
-
Drug tapering noninferior to treatment continuation for rheumatoid arthritis with low disease activity
United Kingdom
-
Toddler EEG study shows why story time and playtime really matter
United Kingdom
-
ACLM launches resources to meet new medical nutrition requirements
United Kingdom
-
Topical peptide spray outperforms placebo in healing burn wounds
United Kingdom